LYVE1 and neoplasm: Next, we performed staining for CD31 and LYVE-1 to study tumor invasion into the vein and lymph vessels, respectively (Fig. 2g), because invasion of PDAC cells was inhibited by CXCR2 inhibitor in vitro.